Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3971-3976

  Romeike, Bernd F M ^a   Hellwig, Dirk ^a   Heimann, Axel ^b   Kempski, Oliver ^b   Feiden, Wolfgang ^a   Kirsch, Carl Martin ^a   Samnick, Samuel ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Brain cancer; Experimental treatment; Glioma therapy; Iodine 131 labelled amino acid; Preclinical study

Indexed keywords

4 IODOPHENYLALANINE I 131; IODINE 131; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG; 4 IODOPHENYLALANINE; 4-IODOPHENYLALANINE; DRUG DERIVATIVE; PHENYLALANINE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CANCER INFILTRATION; CANCER MODEL; CANCER SURVIVAL; CELL COUNT; CONTROLLED STUDY; DEATH; DRUG EFFICACY; GIANT CELL; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TREATMENT OUTCOME; WEIGHT GAIN; ANIMAL; BRAIN TUMOR; GLIOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOBLASTOMA; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; PHENYLALANINE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR;

EID: 14944364815     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H and Cavenee WK: Astrocytic tumours. Oligodendroglial tumours and mixed gliomas. In: Pathology and Genetics of Tumours of the Nervous System (Kleihues P and Cavenee WK, eds). Lyon, IARC Press, 2000, pp 9-69.
2. Daumas-Duport C, Scheithauer B, O'Fallon J and Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62: 2152-2165, 1988.
3. Bowers G, He J, Schulz K, Olivarria G, Maneval D and Olson JJ: Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 91 and RG2 models. Front Biosci 8: a54-61, 2003.
4. Loynes J and Zacharski L: The coagulation system as a target for experimental therapy of human gliomas. Expert Opin Ther Targets 7: 399-404, 2003.
5. Perkins E, Calvert J, Lancon JA, Parent AD and Zhang J: Inhibition of H-ras as a treatment for experimental brain C6 glioma. Brain Res Mol Brain Res 1: 42-51, 2003.
6. Steinbach JP and Weller M: Mechanisms of apoptosis in central nervous system tumors: application to theory. Curr Neurol Neurosci Rep 2: 246-253, 2002.
7. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ and Stummer W: Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 97: 970-976, 2002.
8. Stander M, Naumann U, Wick W and Weller M: Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296: 221-227, 1999.
9. Kock H, Harris MP, Anderson SC, Machemer T, Hancock W, Sutjipto S, Wills KN, Gregory RJ, Shepard HM, Westphal M and Maneval DC: Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer 67: 808-815, 1996.
10. Samnick S, Richter S, Romeike BF, Heimann A, Feiden W, Kempski O and Kirsch CM: Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats. Eur J Nucl Med 27: 1543-1551, 2000.
11. 123I]iodo-L-phenylalanine for routine brain tumour imaging. Nucl Med Commun 23: 121-130, 2002.
12. 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry. Br J Cancer 67: 144-151, 1993.
13. Zalutsky MR and Bigner DD: Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates. Acta Oncol 35: 373-379, 1996.
14. Brady LW, Markoe AM, Woo DV, Amendola BE, Karlsson UL, Rackover MA, Koprowski H, Steplewski Z and Peyster RG: Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. A pilot study. Front Radiat Ther Oncol 24: 151-165, 1990.
15. Kempski O, Chaussy L, Gross U, Zimmer M and Baethmann A: Volume regulation and metabolism of suspended C6 glioma cells: an in vitro model to study cytotoxic brain edema. Brain Res 279: 217-228, 1983.
16. Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek J and Reulen HJ: In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 45: 160-169, 1998.
17. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ and Piers DA: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42: 432-445, 2001.
18. Laverman P, Boerman OC, Corstens FH and Oyen WJ: Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 29: 681-690, 2002.
19. Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BF, Feiden W and Kirsch CM: Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 20: 396-404, 2002.
20. Samnick S, Schaefer A, Siebert S, Richter S, Vollmar B and Kirsch CM: Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells. Nucl Med Biol 28: 13-23, 2001.
21. Brandes A, Soesan M and Florentino M: Medical treatment of high grade malignant gliomas in adults: an overview. Anticancer Res 11: 719-728, 1991.
22. Behr TM, Wormann B, Gramatzki M, Riggert J, Gratz S, Behe M, Griesinger F, Sharkey RM, Kolb HJ, Hiddemann W, Goldenberg DM and Becker W: Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies. Clin Cancer Res 5: 3304-3314, 1999.
23. Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B et al: Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329: 1219-1224, 1993.